ArticleAdvances in therapy2026

Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.

Akemi Sebata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.